Hove, K D3; Brøns, Cecilie4; Færch, Kai Erik Vinther5; Lund, S S3; Petersen, J S3; Karlsen, A E3; Rossing, Pia6; Rehfeld, J F3; Vaag, A7
1 Graduate School of Health and Medical Sciences, Faculty of Health and Medical Sciences, Københavns Universitet2 Section of Orthopaedics and Internal Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet3 unknown4 Saxo-Instituttet - Arkæologi, Etnologi, Historie o5 Institut for Kultur og Globale Studier6 Finance Division7 Graduate School of Health and Medical Sciences, Faculty of Health and Medical Sciences, Københavns Universitet
a randomised double-blind prospective placebo-controlled study
Recent studies suggest that proton pump inhibitor treatment may increase insulin secretion and improve glucose metabolism in type 2 diabetes. In a randomised double-blind prospective placebo-controlled 2 × 2 factorial study, we examined the effect of esomeprazole on insulin secretion, HbA(1c) and cardiovascular risk factors in type 2 diabetes.
Diabetologia, 2013, Vol 56, Issue 1, p. 22-30
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't